Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $145,905 | 48 | 99.5% |
| Food and Beverage | $700.86 | 13 | 0.5% |
| Education | $99.99 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $145,911 | 49 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $184.55 | 2 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $139.28 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $130.68 | 1 | $0 (2024) |
| Alcon Vision LLC | $109.44 | 3 | $0 (2024) |
| Allergan, Inc. | $99.99 | 1 | $0 (2020) |
| ANI Pharmaceuticals, Inc. | $75.21 | 3 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $32.70 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $23.06 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85,720 | 38 | Regeneron Pharmaceuticals, Inc. ($85,111) |
| 2023 | $60,821 | 22 | Regeneron Pharmaceuticals, Inc. ($60,800) |
| 2022 | $65.04 | 1 | Alcon Vision LLC ($65.04) |
| 2020 | $99.99 | 1 | Allergan, Inc. ($99.99) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $38.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $32.70 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $4,083.33 | General |
| 07/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $1,996.04 | General |
| 07/15/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $4,083.33 | General |
| 07/15/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $1,996.04 | General |
| 07/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 06/30/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $4,083.33 | General |
| 06/30/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $1,996.04 | General |
| 06/25/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $130.68 | General |
| Category: Ophthalmology | ||||||
| 06/15/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $4,083.33 | General |
| 06/15/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $1,996.04 | General |
| 05/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $4,083.33 | General |
| 05/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $1,996.04 | General |
| 05/15/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $4,083.33 | General |
| 05/15/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $1,996.04 | General |
| 05/03/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VYZULTA | Food and Beverage | In-kind items and services | $139.28 | General |
| Category: Ophthalmology | ||||||
| 05/02/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 04/30/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $4,083.33 | General |
| 04/30/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $1,996.04 | General |
| 04/15/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $4,083.33 | General |
| 04/15/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $1,996.04 | General |
| 03/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $4,083.33 | General |
| 03/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Grant | Cash or cash equivalent | $1,996.04 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 25 | 25 | $2,118 | $1,091 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $1,106 | $834.54 | 75.5% |
| 92134 | Imaging of retina | Office | 2023 | 11 | 11 | $1,012 | $256.74 | 25.4% |
About Ankur Gupta, MD, MS
Ankur Gupta, MD, MS is a Retina Specialist healthcare provider based in Valencia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1669869848.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ankur Gupta, MD, MS has received a total of $146,706 in payments from pharmaceutical and medical device companies, with $85,720 received in 2024. These payments were reported across 62 transactions from 9 companies. The most common payment nature is "Grant" ($145,905).
As a Medicare-enrolled provider, Gupta has provided services to 25 Medicare beneficiaries, totaling 25 services with total Medicare billing of $1,091. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Retina Specialist
- Other Specialties Student in an Organized Health Care Education/Training Program, Ophthalmology
- Location Valencia, CA
- Active Since 04/24/2015
- Last Updated 05/16/2025
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1669869848
Products in Payments
- ACTHAR (Biological) $184.55
- XIPERE (Drug) $139.28
- Izervay (Drug) $130.68
- Clareon (Device) $109.44
- PURIFIED CORTROPHIN GEL (Drug) $75.21
- XDEMVY (Drug) $32.70
- EYLEA HD (Biological) $29.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.